Biological variation in urinary excretion of pyridinium crosslinks: recommendations for the optimum specimen.
We assessed the analytical and biological variation of pyridinium crosslinks in early morning, 2 h fasting, and 24 h urine specimens from 14 healthy adults over a 1 month period. The results were expressed both in terms of pyridinoline concentration and pyridinoline/creatinine ratio. The data obtained were used to select the optimum specimen for clinical purposes. We found that: (a) early morning specimens are preferred; (b) results should be expressed as pyridinoline/creatinine ratio; (c) reference intervals should be stratified according to gender; (d) the necessary analytical imprecision (CV < or = 9%), derived from biological variation, is not easily achieved by current methods; (e) the difference between serial results from an individual must be > 50% to be statistically significant; and (f) assessment of risk for osteoporotic fracture by means of the pyridinium crosslink assay would, in a significant number of patients, require analysis of multiple urine specimens.
Panteghini
M
M
1st Laboratory of Clinical Chemistry, Spedali Civili, Brescia, Italy.
Pagani
F
F
D000328:Adult; D000596:Amino Acids / Q000652:urine*; D000704:Analysis of Variance; D005215:Fasting; D005260:Female; D006801:Humans; D008297:Male; D013997:Time Factors
D000596:Amino Acids; C015484:pyridinoline; C036020:deoxypyridinoline